Air T is a holding company. Through its subsidiaries, the company operates the following industry segments: overnight air cargo, which operates in the air express delivery services industry; ground equipment sales, which manufactures and provides mobile deicers and other equipment products; ground support services, which provides ground support equipment maintenance and facilities maintenance services; commercial aircraft, engines and parts, which provides services including commercial aircraft disassembly/part-out services; and printing equipment and maintenance, which designs, manufactures and sells digital print production equipment and provides maintenance services to commercial customers.

Altisource Portfolio Solutions is a marketplace and transaction solutions provider for the real estate, mortgage and consumer debt industries. Co. has three reportable segments: mortgage services, which provides asset management services, origination services, insurance services, property valuation services, and default management services; financial services, which provides collection services primarily to debt originators and servicers and customer relationship management services primarily to the utility, insurance and hotel industries; and technology services, which provides software and data analytics solutions and information technology infrastructure management services.

Blue Apron provides recipes, ingredients, and cooking techniques to preparing meals to sharing photos and stories of culinary triumphs. The company also sells wine, which can be paired with its meals, and the company sells a curated selection of cooking tools, utensils, and pantry items. The company's products include: Meals, which provides a 2-Person Plan that serves two people, and a Family Plan that serves four people; Wine, which provides wine delivery service, including red and white wines (and roses, depending on the season), tasting notes, pairing tips, and the story behind each wine; and Market, which provides a selection of cooking tools, utensils, and pantry items.

Ecology and Environment is an environmental consulting firm. Primary markets that the company participates in, and the services it provides to clients within those markets, are as follows: Energy, which includes projects related to fossil fuels, renewables, and electric transmission; Site Assessment and Remediation, in which the company provides a variety of services related to environmental liabilities from hazardous waste sites; Armed Services, which provides real property master planning, military programming, geospatial data and systems support, and database management, among others; Federal Lands and Waters; International and Communications; Resilient Communities; and Water and Ecosystem Restoration.

FNB Bancorp is a bank holding company. The company operates through its subsidiary, First National Bank of Northern California (the Bank). The Bank's market areas consist of the counties of San Francisco, San Mateo and Santa Clara. The Bank provides a range of services to individuals and businesses in its primary service area, including business financial products with services such as courier and appointment banking. The Bank provides personal and business checking and savings accounts, including money market accounts. The Bank also makes available commercial loans and standby letters of credit. As of Dec 31 2016, the company had total assets of $1.22 billion and total deposits of $1.02 billion.

Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics. JAKAFI (ruxolitinib) has been approved for the treatment of patients with intermediate or high-risk myelofibrosis, for the treatment of patients with polycythemia vera, and for the treatment of steroid-refractory acute graft-versus-host disease in adult and pediatric patients 12 years and older. The company has also obtained a license to develop and commercialize ICLUSIG (ponatinib) in Europe and other select countries. In the European Union, ICLUSIG is approved for the treatment of adult patients with chronic phase, accelerated phase or blast phase chronic myeloid leukemia.

Intercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat progressive non-viral liver diseases. The company's marketed product, Ocaliva? (obeticholic acid or OCA), is an farnesoid X receptor agonist approved in the U.S., the European Union and several other jurisdictions for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. In addition to, the company is developing OCA for multiple indications, including nonalcoholic steatohepatitis.

International Flavors & Fragrances is a creator and manufacturer of taste, scent and complementary adjacent products, including cosmetic active and natural health ingredients. The company's operating segments are Taste and Scent. The Taste segment develops a range of different flavors and taste offerings for its customers, most of which are tailor-made. The company's Taste business is comprised of various portfolios across flavor compounds, savory solutions, inclusions and nutrition and specialty ingredients. The Scent segment creates fragrance compounds and fragrance ingredients for the household and personal care products. The company also produces cosmetic active and functional ingredients for use in cosmetics.

CenturyLink, via its subsidiaries, is a communications company engaged in providing an array of integrated services to its business and residential customers. The company's segments include: International and Global Accounts Management, which provides products and services to global enterprise customers; Enterprise, which provides products and services to regional domestic and global enterprises; Small and Medium Business, which provides products and services to small and medium businesses directly and through its indirect channel partners; and Wholesale, which provides products and services to other communication providers across the wireline, wireless, cable, voice and data center sectors.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Radius Health is a biopharmaceutical company focused on developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company's commercial product, TYMLOSTM (abaloparatide) injection is designed for the treatment of postmenopausal women with osteoporosis at high risk for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. The company is developing an abaloparatide transdermal patch for potential use in the treatment of postmenopausal women with osteoporosis. The company is also developing its Elacestrant, a selective estrogen receptor degrader, for potential use in the treatment of hormone receptor-positive breast cancer.